In CRC cells, baicalin treatment induced cell cycle arrest in the G1 phase, promoted p53-independent apoptosis, and prevented both exogenous and endogenous TGFβ1-induced epithelial–mesenchymal transition in CRC cells by inhibiting the TGF-β/Smad pathway. Here, TGFB1 is linked to colorectal carcinoma.